- Feedback from Quebec-based employees through the Trust Index survey contributed to the certification
- High employee satisfaction with the Novartis programs and practices are key components of this year's ranking
DORVAL, QC, June 23, 2020 /CNW/ - Novartis in Canada has been named to the list of Best Workplaces in Quebec for the second consecutive year. This distinction follows the company's certification as a nationally ranked Great Place to Work®. This ranking was made possible thanks to the feedback from Quebec-based employees across the Novartis businesses including the Innovative Medicines Division (Pharmaceuticals and Oncology business units), as well as Sandoz Canada. The survey gathered employee opinion on the programs and practices that they feel makes their workplace unique.
"Earning a coveted spot on this list for a second year in a row is a testament to the shift in culture to one that is inspired, curious and unbossed and unleashes the power of our people. Being recognized by the Great Place to Work® Institute is an honour for Novartis. I am most proud of the fact that our associates feel their contribution to reimagining medicines for Canadian patients is valued and that the investment in our employees is appreciated by them," said Christian Macher, Country President, Novartis Pharmaceuticals Canada Inc. "Novartis is represented across this great country with the majority of associates based in Quebec and is why being named to the list in Quebec speaks highly about our workplace excellence to our reputation as an organization."
The Novartis team in Canada is motivated to deliver on the company's commitment to patients. Associates know Canadians are counting on Novartis to continue to provide the medicines they need to stay as healthy as possible and to treat serious conditions they live with. The dedication of Novartis associates is characterized by the values of the organization. At this unprecedented time when patients are counting on Novartis more than ever, the high level of engagement and flexibility of associates is clearly evident.
The team consists of approximately 1,500 associates, more than two thirds of which are based in Quebec where Novartis in Canada is headquartered. Novartis is powered by innovation and aims to foster creative thinking to help deliver on the company's purpose of improving and extending people's lives.
Organizations who are included on the Best Workplaces™ in Quebec list are determined based on the overall Trust Index score from employees working in the province. They must be Great Place to Work Certified™ in the past year, be headquartered in Quebec, be working towards building a great workplace culture and have at least 10 employees working in the province that participated in the survey.
About Great Place to Work®
Great Place to Work® is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, GPTW recognizes the world's Best Workplaces™ in a series of national lists including those published by The Globe & Mail (Canada) and Fortune magazine (USA). Great Place to Work® provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. Visit us at www.greatplacetowork.ca or find us on Twitter at @GPTW_Canada.
About Novartis in Canada
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2019, the company invested $51.8 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 1,500 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.
About Sandoz in Canada
Sandoz Canada Inc. is part of Sandoz International GmbH, a global leader in generic pharmaceuticals and biosimilars and a pioneer in the emerging field of prescription digital therapeutics, and a division of Swiss multinational Novartis AG. A leader in its field, Sandoz in Canada, manufactures, markets and distributes a broad line of generic, biosimilar and specialty products. For more information, visit www.sandoz.ca.
Follow us on LinkedIn: https://www.linkedin.com/company/sandoz-canada/
About Novartis globally
Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at www.novartis.com.
SOURCE Novartis Pharmaceuticals Canada Inc.
Novartis Media Relations, Stephanie Weinstein, Novartis Corporate Communications, +1 514 633 7873, E-mail: [email protected]
Share this article